# 2025-15153: Veterans Pharmaceuticals Applies for DEA Nod on Controlled Drug Imports

2025-15153, Importer of Controlled Substances Application: Veterans Pharmaceuticals, Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-08-11 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-15153
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-15153
- Title: Importer of Controlled Substances Application: Veterans Pharmaceuticals, Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 38664
- Published: 2025-08-11
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Veterans Pharmaceuticals Applies for DEA Nod on Controlled Drug Imports

## Summary

Veterans Pharmaceuticals, Inc. wants to get official approval to bring in certain controlled substances. This means they’ll be able to import these drugs legally, which could affect how these medicines reach the market. Keep an eye out for updates on their registration status and any related deadlines or fees.

## Abstract

Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-15153 on federalregister.gov](https://www.federalregister.gov/documents/2025/08/11/2025-15153/importer-of-controlled-substances-application-veterans-pharmaceuticals-inc)
- [2025-15153 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-08-11/pdf/2025-15153.pdf)

## Related
- [Previous: 2025-15152, Privacy Act of 1974; Matching Program](https://policyrisk.com/federal-register/2025-15152)
- [Next: 2025-15154, Applications for New Awards; Assistance for Arts Education Program](https://policyrisk.com/federal-register/2025-15154)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-15153 (as of 2026-06-08).